GLORIA

GEOMAR Library Ocean Research Information Access

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    In: The Journal of Vascular Access, SAGE Publications
    Abstract: Our objective was to identify central line (CL)-associated bloodstream infections (CLABSI) rates and risk factors (RF) in Asia. Methods: From 03/27/2004 to 02/11/2022, we conducted a multinational multicenter prospective cohort study in 281 ICUs of 95 hospitals in 44 cities in 9 Asian countries (China, India, Malaysia, Mongolia, Nepal, Pakistan, Philippines, Sri Lanka, Thailand, and Vietnam). For estimation of CLABSI rate we used CL-days as denominator and number of CLABSI as numerator. To estimate CLABSI RF for we analyzed the data using multiple logistic regression, and outcomes are shown as adjusted odds ratios (aOR). Results: A total of 150,142 patients, hospitalized 853,604 days, acquired 1514 CLABSIs. Pooled CLABSI rate per 1000 CL-days was 5.08; per type of catheter were: femoral: 6.23; temporary hemodialysis: 4.08; jugular: 4.01; arterial: 3.14; PICC: 2.47; subclavian: 2.02. The highest rates were femoral, temporary for hemodialysis, and jugular, and the lowest PICC and subclavian. We analyzed following variables: Gender, age, length of stay (LOS) before CLABSI acquisition, CL-days before CLABSI acquisition, CL-device utilization ratio, CL-type, tracheostomy use, hospitalization type, ICU type, facility ownership and World Bank classifications by income level. Following were independently associated with CLABSI: LOS before CLABSI acquisition, rising risk 4% daily (aOR = 1.04; 95% CI = 1.03–1.04; p  〈  0.0001); number of CL-days before CLABSI acquisition, rising risk 5% per CL-day (aOR = 1.05; 95% CI 1.05–1.06; p  〈  0.0001); medical hospitalization (aOR = 1.21; 95% CI 1.04–1.39; p = 0.01); tracheostomy use (aOR = 2.02;95% CI 1.43–2.86; p  〈  0.0001); publicly-owned facility (aOR = 3.63; 95% CI 2.54–5.18; p  〈  0.0001); lower-middle-income country (aOR = 1.87; 95% CI 1.41–2.47; p  〈  0.0001). ICU with highest risk was pediatric (aOR = 2.86; 95% CI 1.71–4.82; p  〈  0.0001), followed by medical-surgical (aOR = 2.46; 95% CI 1.62–3.75; p  〈  0.0001). CL with the highest risk were internal-jugular (aOR = 3.32; 95% CI 2.84–3.88; p  〈  0.0001), and femoral (aOR = 3.13; 95% CI 2.48–3.95; p  〈  0.0001), and subclavian (aOR = 1.78; 95% CI 1.47–2.15; p  〈  0.0001) showed the lowest risk. Conclusions: The following CLABSI RFs are unlikely to change: country income level, facility-ownership, hospitalization type, and ICU type. Based on these findings it is suggested to focus on reducing LOS, CL-days, and tracheostomy; using subclavian or PICC instead of internal-jugular or femoral; and implementing evidence-based CLABSI prevention recommendations.
    Type of Medium: Online Resource
    ISSN: 1129-7298 , 1724-6032
    Language: English
    Publisher: SAGE Publications
    Publication Date: 2023
    detail.hit.zdb_id: 2079292-X
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    Online Resource
    Online Resource
    SAGE Publications ; 2019
    In:  Advances in Mechanical Engineering Vol. 11, No. 6 ( 2019-06), p. 168781401985194-
    In: Advances in Mechanical Engineering, SAGE Publications, Vol. 11, No. 6 ( 2019-06), p. 168781401985194-
    Abstract: Nanomaterial, as a new emerging material in the field of civil engineering, has been widely utilized to enhance the mechanical properties of cementitious material. Nano-SnO 2 has presented high hardness characteristics, but there is little study of the application of nano-SnO 2 in the cementitious materials. This study mainly investigated the hydration characteristics and strength development of Portland cement paste incorporating nano-SnO 2 powders with 0%, 0.08%, and 0.20% dosage. It was found that the early-age compressive strength of cement paste could be greatly improved when nano-SnO 2 was incorporated with 0.08% dosage. The hydration process and microstructure were then measured by hydraulic test machine, calorimeter, nanoindentation, X-ray diffraction, scanning electron microscope, and mercury intrusion porosimetry. It was found that the cement hydration process was promoted by the addition of nano-SnO 2 , and the total amount of heat released from cement hydration is also increased. In addition, the addition of nano-SnO 2 can promote the generations of high density C-S-H and reduce the generations of low density C-S-H indicating the nucleation effect of nano-SnO 2 in the crystal growth process. The porosity and probable pore diameter of cement paste with 0.08% nano-SnO 2 were decreased, and the scanning electron microscopic results also show that the cement paste with 0.08% nano-SnO 2 promotes the densification of cement microstructure, which are consistent with the strength performance.
    Type of Medium: Online Resource
    ISSN: 1687-8140 , 1687-8140
    Language: English
    Publisher: SAGE Publications
    Publication Date: 2019
    detail.hit.zdb_id: 2501620-9
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 3
    In: The Journal of Vascular Access, SAGE Publications
    Abstract: Central line-associated bloodstream infection (CLABSI) rates in intensive care units (ICUs) across Latin America exceed those in high-income countries significantly. Methods: We implemented the INICC multidimensional approach, incorporating an 11-component bundle, in 122 ICUs spanning nine Asian countries. We computed the CLABSI rate using the CDC/NSHN definition and criteria. The CLABSI rate per 1000 CL-days was calculated at baseline and throughout different phases of the intervention, including the 2nd month, 3rd month, 4–16 month, and 17–29 month periods. A two-sample t-test was employed to compare baseline CLABSI rates with intervention rates. Additionally, we utilized a generalized linear mixed model with a Poisson distribution to analyze the association between exposure and outcome. Results: A total of 124,946 patients were hospitalized over 717,270 patient-days, with 238,595 central line (CL)-days recorded. The rates of CLABSI per 1000 CL-days significantly decreased from 16.64 during the baseline period to 6.51 in the 2nd month (RR = 0.39; 95% CI = 0.36–0.42; p 〈 0.001), 3.71 in the 3rd month (RR = 0.22; 95% CI = 0.21–0.25; p 〈 0.001), 2.80 in the 4–16 month (RR = 0.17; 95% CI = 0.15–0.19; p 〈 0.001), and 2.18 in the 17–29 month (RR = 0.13; 95% CI = 0.11–0.15; p 〈 0.001) intervals. A multilevel Poisson regression model demonstrated a sustained, continuous, and statistically significant decrease in ratios of incidence rates, reaching 0.35 ( p 〈 0.0001) during the 17–29 month period. Moreover, the all-cause in-ICU mortality rate significantly decreased from 13.23% to 10.96% ( p = 0.0001) during the 17–29 month period. Conclusions: Our intervention led to an 87% reduction in CLABSI rates, with a 29-month follow-up.
    Type of Medium: Online Resource
    ISSN: 1129-7298 , 1724-6032
    Language: English
    Publisher: SAGE Publications
    Publication Date: 2024
    detail.hit.zdb_id: 2079292-X
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...